Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
NHA invites comments on consultation paper on drug registry
The drug registry intends to create a nationally recognised source of truth for information on various systems of medicine in the…
FDA authorises second booster of Pfizer/BioNTech and Moderna COVID shots
The agency said the new boosters - a fourth round of shots for most vaccine recipients - of the Pfizer Inc/BioNTech SE and Moderna…
Monetisation of healthcare: New avenues for patient revenue
Amaninder S Dhillon, Pharma Marketer, D Passion Consultant, Oncology/Superspeciality, explains how patients' data sharing is a way…
BioNTech to expand trial programme for more anti-Omicron vaccine options
Data is expected in April, the company said in a statement yesterday
COVID-19 vaccine: NTAGI to review Covovax data for use in kids aged 12 years and above
India's drug regulator had approved Covovax for restricted use in emergency situations in adults on 28th December, 2021, and those…
New cancer immunotherapy fails in first Roche trial
The Skyscraper-II trial was the first to produce results in the final stage of clinical testing in a class of drugs known as…
GE Healthcare announces first patient dosed in phase-III clinical trial for new dopamine transporter…
Next-stage clinical study also proceeding for SPECT radiopharma
Sun Pharma to introduce its version of Vortioxetine in India
Vortioxetine is a novel antidepressant with multimodal activity, which is approved to treat Major Depressive Disorder (MDD) in…
Sanofi and IGM Biosciences announce collaboration agreement for oncology, immunology and…
Collaboration to create, develop, manufacture and commercialise new class of potential therapeutics combining the superior…
US FDA approves Novo Nordisk’s Ozempic 2 mg to treat type-II diabetes
Ozempic demonstrated 2.1 per cent blood sugar reduction and also weight loss in adults with type-II diabetes with new 2 mg dose